Determination of intracellular Th1/Th2 type cytokines in lymphocytes of chronic hepatitis B patients treated with interferon-alpha

Turkish Journal of Gastroenterology

Volumn 21, Issue 4, 2010, Pages 401-410

  Atan, Özlem ^a   Aksu, Güzide ^a   Özgenç, Funda ^a   Akman, Sezin A ^b   Karaca, Neslihan Edeer ^a   Sertoz, Ruchan ^c   Yaǧci, Raşit Vural ^a   Kütükçüler, Necil ^a  

^a Department of Pediatrics ^*  (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c Soc Sec Tepecik Children's Hosp   (Turkey)

Author keywords

Chronic hepatitis B; Cytotoxic T cell; Helper T cell; Interferon alpha; Intracellular cytokines

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTRON 2A; RECOMBINANT ALPHA2A INTERFERON; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HEPATITIS B; HUMAN; LIVER FUNCTION TEST; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

ADOLESCENT; ANTIVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CYTOKINES; DRUG MONITORING; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; TH1 CELLS; TH2 CELLS;

EID: 79951977484     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0127     Document Type: Article

References (28)

1. Toukan AU. Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection. Gut 1996; 38 (Suppl 2): S2-4.
2. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med 2007; 12: 160-7.
3. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45. (Pubitemid 27527771)
4. Thimme R, Wieland S, Steiger C, et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77: 68-76. (Pubitemid 36004947)
5. Carey I, Vergani D. The role of viral-specific immune responses on the outcome of chronic hepatitis B (HBV) infection in children: new insights into immunopathology. J Pediatr Gastroenterol Nutr 2007; 45: 15-8. (Pubitemid 47012325)
6. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107. (Pubitemid 38365759)
7. Fischler B, Nyström J, Björnsdottir T, et al. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection. J Pediatr Gastroenterol Nutr 2007; 45: 75-83. (Pubitemid 47012334)
8. Okuno T, Shindo M, Arai K, et al. Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes. Gastroenterol Jpn 1990; 25: 70-7. (Pubitemid 20104375)
9. Jung T, Schauer U, Heusser C, et al. Detection of intracellular cytokines by flow cytometry. J Immunol Meth 1993; 159: 197-207.
10. Prussin C, Metcalfe D. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anticytokine antibodies. J Immunol Meth 1995; 188: 117-28. (Pubitemid 26011539)
11. Sander B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and the paraformalde-hydesaponin procedure. Immunol Rev 1991; 119: 65-93.
12. Wong DK, Cheung AM, O'Rouke K, et al. Effect of interferon alpha treatment in patients with hepatitis B e antigen positive chronic hepatitis B. A meta analysis. Ann Intern Med 1993; 119: 312-5.
13. Lok AS. Antiviral therapy for the Asian patients with chronic hepatitis B. Semin Liver Dis 1993; 13: 360-6. (Pubitemid 24007139)
14. Van Zonneveld M, Hankoop P, Hansen BE, et al. Long term follow up of alpha interferon treatment of patients with chronic hepatitis B. Hepatology 2004; 39: 804-8.
15. Norder H, Hammas B, Lee SD, et al. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993; 74: 1341-6.
16. Erhardt A, Reineke U, Blondin D, et al. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 2000; 31: 716-25. (Pubitemid 30118641)
17. Im EH, Lee BS, Sung JK, et al. T cell subsets in chronic hepatitis B and the effect of prednisolone withdrawal and interferon alpha 2-b. Korean J Intern Med 1999; 14: 1-8.
18. Pham BN, Mosnier JF, Walker F, et al. Flow cytometry CD4+/CD8+ ratio of liver derived lymphocytes correlates with viral replication in chronic hepatitis B. Clin Exp Immunol 1994; 97: 403-10. (Pubitemid 24283882)
19. Kakumu S, Yoshioka K, Wakita T, Ishikawa T. Comparisons of peripheral blood and hepatic lymphocyte subpopulations and interferon production in chronic viral hepatitis. J Clin Lab Immunol 1990; 33: 1-6.
20. Unal F, Genel F, Ozgenc F, et al. Immune status and autoantibody formation in children with chronic hepatitis B infection. Panminerva Med 2002; 44: 353-7. (Pubitemid 41328281)
21. Genel F, Unal F, Ozgenc F, et al. Decreased ratio of CD4/CD8 lymphocytes might be predictive for successful interferon alpha and lamuvidine combined therapy in childhood chronic hepatitis B infection: a preliminary study. J Gastroenterol Hepatol 2003; 18: 645-50. (Pubitemid 36791701)
22. Gilles P, Fey G, Chisari FV. TNF alpha negatively regulates HBV gene expression in transgenic mice. J Virol 1996; 74: 49-55.
23. Maruyama T, Schodel F, Lino S, et al. Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology 2001; 106: 1006-15.
24. Xing T, Zhang L, Lu Q, et al. Th1/Th2 type cytokines in hepatitis B patients treated with interferon alpha. Chin Med J 2001; 114: 921-8.
25. Jiang R, Feng X, Guo Y, et al. T helper cells in patients with chronic hepatitis B virus infection. Chin Med J 2000; 113: 132-3.
26. Lee M, Lee M, Lee SK, et al. Expression of Th1 and Th2 type cytokines responding to HbsAg in chronic hepatitis B patients. J Korean Med Sci 1999; 2: 175-81.
27. Huang Y, Chen Z, Jia H, et al. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg. Clin Immunol 2006; 2: 16-24.
28. Loggi E, Gramenzi A, Margotti M, et al. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. J Viral Hepat 2008; 15: 442-8.